Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA May Adopt ISO 13485 If Certain Changes Are Made

This article was originally published in The Silver Sheet

Executive Summary

ISO 13485, THE INTERNATIONAL QUALITY SYSTEM STANDARD, may ultimately be incorporated into FDA's Quality System Regulation - or the regulation could be replaced altogether - but the agency would want specific changes made to the ISO standard first. While the two documents are similar in many respects, "two very important issues" would have to aligned, says FDA GMP expert Kim Trautman: process validation and software validation. Industry experts comment on key differences between ISO 13485 and the QSR, and urge companies to refer to a little-known guidance document, ISO 14969, which offers advice on applying the ISO quality system standard

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT036302

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel